Security key
75943R102
Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY)
CUSIP: 75943R102
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 170,927,354
- Total 13F value
- $591,366,333
- Share change
- +8,246,591
- SEC-reported price per share
- $3.46
- Number of holders
- 203
- Value change
- +$36,190,035
- Number of buys
- 105
- Number of sells
- 87
- Shares outstanding
- 4,389,099
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
203
Top holders
10
RLAY full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Relay Therapeutics, Inc. SEC filings
Relay Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75943R102
Recent filing periods:
Ownership snapshot
Top reported holders of RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
SB INVESTMENT ADVISERS (U...
Comparable rows
15/15
Latest evidence
31 Mar 2025
13F
13D/G
Lead comparable stake: 6.1%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 6.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
6.1%
SB INVESTMENT ADVISERS (UK) LTD
636%
VANGUARD GROUP INC
276%
Point72 Asset Management, L.P.
247%
Casdin Capital, LLC
207%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
6.1%
from 13D/G
|
$37,934,451
14,478,798 shares
|
— | 31 Mar 2025 |
| SB INVESTMENT ADVISERS (UK) LTD |
13F
Company
|
636%
|
$73,111,003
27,904,963 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
276%
|
$31,716,201
12,105,420 shares
|
— | 31 Mar 2025 |
| Point72 Asset Management, L.P. |
13F
Company
|
247%
|
$28,366,917
10,827,067 shares
|
— | 31 Mar 2025 |
| Casdin Capital, LLC |
13F
Company
|
207%
|
$23,838,264
9,098,574 shares
|
— | 31 Mar 2025 |
| TANG CAPITAL MANAGEMENT LLC |
13F
Company
|
184%
|
$21,138,312
8,068,058 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
203
Shares
170,927,354
Rows available
203
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
205
Q2 2025 holders
203
Holder diff
-2
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend